So when a drug goes under shortage, that essentially gives authority to these compounders to start producing them, you know, to fill in these access gaps
In addition, participants with missing outcome variables, under 18 years old, and those with no history of diabetes or/and obesity were excluded

A Decision Framework Choose Semaglutide If: You are starting GLP-1 therapy for the first time and want to begin with the more established, longer-studied option Cost is a tighter constraint and the $50 per injection pricing is important Your weight loss goal is moderate (10-15% of body weight) and semaglutides proven efficacy range is sufficient Your insurance covers Wegovy or Ozempic, making brand-name semaglutide accessible through a separate pharmacy benefit Choose Tirzepatide If: Maximum weight loss is the priority and you want the most clinically effective option currently available You have tried semaglutide and found the results plateaued before reaching your goal You have Type 2 diabetes, as tirzepatides dual mechanism produces stronger glycemic control alongside weight loss The cost difference between semaglutide and tirzepatide is manageable within your budget You are comfortable using HSA funds to offset the cost of the higher dose tiers What About Compounded Semaglutide and Tirzepatide

This age-related decline parallels other measurable changes like the loss of lean mass and bone density that a DEXA scan can quantify
Protecting Muscle & Bone Mass About 20%, up to 40% (Spreckley 2026) of total weight lost can come from muscle tissuesomething especially concerning for women in perimenopause or menopause, who are already losing lean mass with age